<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01785641</url>
  </required_header>
  <id_info>
    <org_study_id>RA56/006</org_study_id>
    <nct_id>NCT01785641</nct_id>
  </id_info>
  <brief_title>Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD Patients</brief_title>
  <official_title>Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of single versus combined antibiotic therapy for bacterial
      peritonitis in CAPD patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare relapse and recurrent rate of peritonitis between single and combined antibiotic
      regimens for bacterial peritonitis in CAPD patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>relapse or recurrent rate</measure>
    <time_frame>within 4 weeks after peritonitis treatment</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Peritonitis</condition>
  <arm_group>
    <arm_group_label>ceftazidime+ciprofloxacin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 synergistic antibiotics(ceftazidime IP and ciprofloxacin po for gram negative bacterial peritonitis)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ceftazidime monotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ceftazidime IP for gram negative bacterial peritonitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cefazolin+gentamicin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cefazolin IP and gentamicin IP for gram positive bacterial peritonitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cefazolin monotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cefazolin IP for gram positive bacterial peritonitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ceftazidime+ciprofloxacin</intervention_name>
    <description>2 synergistic antibiotics: ceftazidime IP + ciprofloxacin po for gram negative bacterial peritonitis</description>
    <arm_group_label>ceftazidime+ciprofloxacin</arm_group_label>
    <other_name>combined antibiotic therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ceftazidime monotherapy</intervention_name>
    <description>ceftazidime IP for gram negative bacterial peritonitis</description>
    <arm_group_label>ceftazidime monotherapy</arm_group_label>
    <other_name>monotherapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cefazolin+gentamicin</intervention_name>
    <description>cefazolin IP + gentamicin IP for gram positive bacterial peritonitis</description>
    <arm_group_label>cefazolin+gentamicin</arm_group_label>
    <other_name>combined antibiotic therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cefazolin monotherapy</intervention_name>
    <description>cefazolin IP for gram positive bacterial peritonitis</description>
    <arm_group_label>cefazolin monotherapy</arm_group_label>
    <other_name>monotherapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;/= 18 years old

          -  ESRD patients on continuous ambulatory peritoneal dialysis more than 4 weeks

          -  presence of symptom or sign of peritonitis

          -  presence of WBC &gt;100cell/mm3 with PMN &gt;50% in peritoneal dialysate or gram stain
             positive for gram positive or gram negative bacteria

        Exclusion Criteria:

          -  presence of polymicrobial organism, non-fermentative gram negative organism, fungus,
             mycobacteria in peritoneal fluid or culture-negative

          -  peritonitis from the organisms that required combined antibiotic therapy according to
             ISPD guideline 2010

          -  hospital-acquired peritonitis

          -  presence of catheter-related infection

          -  history of peritonitis within 4 weeks

          -  currently taking antibiotic

          -  allergic to the antibiotic that used in the study(penicillin or cephalosporin or
             quinolone or aminoglycoside)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nalinee Saiprasertkit, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chulalongkorn University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Talerngsak Kanjanabuch, Assoc. Prof.</last_name>
    <phone>662-2564321</phone>
    <phone_ext>211</phone_ext>
    <email>golfnephro@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chulalongkorn university</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nalinee Saiprasertkit, MD.</last_name>
      <phone>66865899700</phone>
      <email>nsaiprasertkit@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Nalinee Saiprasertkit, MD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Worapot Treamtrakanpon, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2013</study_first_submitted>
  <study_first_submitted_qc>February 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2013</study_first_posted>
  <last_update_submitted>February 6, 2013</last_update_submitted>
  <last_update_submitted_qc>February 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>peritoneal dialysis</keyword>
  <keyword>peritonitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peritonitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Ciprofloxacin</mesh_term>
    <mesh_term>Gentamicins</mesh_term>
    <mesh_term>Cefazolin</mesh_term>
    <mesh_term>Ceftazidime</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

